Andrew Reardon, Chief Legal Officer & at LIGAND PHARMACEUTICALS INC (LGND), sold 20,000 shares at $83.04 ($1.7M) on 2024-05-09, disclosed to the SEC on 2024-05-13.
Open-market sale of $1.7M LGND by Chief Legal Officer &. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.04 | 10,000 | $830K | 50.0% |
| 2 | $83.04 | 10,000 | $830K | 50.0% |
| Total | $83.04 avg | 20,000 | $1.7M | 100% |
| Filing → |
| LGND | SELL | 2026-08-04 | $1.4M | — | Filing → |
| LGND | SELL | 2026-07-06 | $1.6M | — | Filing → |
| LGND | SELL | 2026-06-02 | $1.1M | — | Filing → |